...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
Does anyone know which of the other three drugs have been evaluated clinically for any condition and been shown to be safe? And the companies that produce them?